caproate) has been approved by the U.S. Food and Drug Administration to
help prevent birth before 37 weeks of pregnancy in women who have had at
least one prior early delivery.
mesothelioma treatment pleural mesothelioma mesothelioma treatments
Samstag, 5. Februar 2011
Drug Approved to Help Prevent Preterm Birth (HealthDay)
HealthDay - FRIDAY, Feb. 4 (HealthDay News) -- Makena (hydroxyprogesterone
caproate) has been approved by the U.S. Food and Drug Administration to
help prevent birth before 37 weeks of pregnancy in women who have had at
least one prior early delivery.
caproate) has been approved by the U.S. Food and Drug Administration to
help prevent birth before 37 weeks of pregnancy in women who have had at
least one prior early delivery.
Abonnieren
Kommentare zum Post (Atom)
Keine Kommentare:
Kommentar veröffentlichen